Using a covered stent for large cerebral aneurysms treated with stent-assisted coiling

Fang, Cong; Chuan-sen, Liu; Xiao, Yaping; Zhao, Mei; Zhang, Jianmin; Li, Minghua; Zhang, Donghui

doi:10.1177/1591019915581993

Cited by 3 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fewer mass effects have been observed with stent graft compared with coils and Onyx in the treatment of cerebral aneurysms. 12 Aneurysms treated with covered stents have greatly reduced recurrence rates compared with those treated with coils or liquid embolic materials. 12 Additional data are needed to see if the same applies for the CCFs.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Use of coronary stent grafts for the treatment of high-flow carotid cavernous fistula

et al. 2021

View full text Add to dashboard Cite

Carotid cavernous fistulas are abnormal communications between the carotid artery or its branches and the cavernous sinus. It can be traumatic or spontaneous. The widely accepted treatment is by detachable balloons. Advancements in the field of endovascular medicine made available other options for the treatment of this condition. Covered stents are widely available and offer preservation of the parent artery while occluding the fistula.

show abstract

Section: Discussionmentioning

confidence: 99%

“… 12 Aneurysms treated with covered stents have greatly reduced recurrence rates compared with those treated with coils or liquid embolic materials. 12 Additional data are needed to see if the same applies for the CCFs.…”

Section: Discussionmentioning

confidence: 99%

Use of coronary stent grafts for the treatment of high-flow carotid cavernous fistula

et al. 2021

View full text Add to dashboard Cite

show abstract

“…To date, there is a paucity of data available regarding the use of liquid embolics in aneurysm treatment. The use of covered stents for treating aneurysms has also been demonstrated in a few clinical studies [ 80 ]. The main advantage of covered stents over FD is the immediate protection against rupture.…”

Section: Newer Devicesmentioning

confidence: 99%

The Management of Intracranial Aneurysms: Current Trends and Future Directions

Deshmukh,

Priola,

Katsanos

et al. 2024

Neurology International

View full text Add to dashboard Cite

Intracranial aneurysms represent a major global health burden. Rupture of an intracranial aneurysm is a catastrophic event. Without access to treatment, the fatality rate is 50% in the first 30 days. Over the last three decades, treatment approaches for intracranial aneurysms have changed dramatically. There have been improvements in the medical management of aneurysmal subarachnoid haemorrhage, and there has been an evolution of treatment strategies. Endovascular therapy is now the mainstay of the treatment of ruptured intracranial aneurysms based on robust randomised controlled trial data. There is now an expansion of treatment indications for unruptured intracranial aneurysms to prevent rupture with both microsurgical clipping and endovascular treatment. Both microsurgical and endovascular treatment modalities have evolved, in particular with the introduction of innovative endovascular treatment options including flow diversion and intra-saccular flow disruption. These novel therapies allow clinicians to treat more complex and previously untreatable aneurysms. We aim to review the evolution of treatment strategies for intracranial aneurysms over time, and discuss emerging technologies that could further improve treatment safety and functional outcomes for patients with an intracranial aneurysm.

show abstract

The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience

Morsi,

Thind,

Chahine

et al. 2024

J NeuroIntervent Surg

View full text Add to dashboard Cite

BackgroundThe use of covered stent grafts for the treatment of carotid rupture is increasingly being used given their ability to preserve the parent artery while simultaneously occluding the fistula or rupture point.MethodsThis case series describes the technical feasibility of using, and the performance of, the PK Papyrus covered coronary stent (Biotronik, Inc., Lake Oswego, Oregon, USA) in six patients with carotid rupture, including carotid cavernous fistulas, between July 2021 and October 2023 in a single-center institution in the USA.ResultsThe median decade of life was 5 (IQR 3) with a 1:1 male-to-female ratio. The majority were black patients (n=5/6, 83.3%). The most common disease pathology was carotid cavernous fistula (n=4/6, 66.7%), followed by traumatic carotid rupture (n=2/6, 33.3%). All the stent embolization procedures were successfully treated with the PK Papyrus covered coronary stent. None of the patients had any recurrence or re-treatment. The number of stents required ranged from 1 to 3. A balloon guide catheter was used in 66.7% of cases (n=4/6). In-hospital mortality was 0.0% (n=0/6). No in-stent thrombosis was observed, but there was one case of cangrelor-associated hemorrhagic stroke conversion. Transfemoral access was used in all cases with one access site complication. Median follow-up time was 1.8 months (IQR 3.5).ConclusionsTo our knowledge, this is the largest case series in the USA demonstrating the feasibility and safety of using the PK Papyrus covered coronary stent for the treatment of carotid rupture, including carotid cavernous fistulas.

show abstract

Using a covered stent for large cerebral aneurysms treated with stent-assisted coiling

Cited by 3 publications

References 24 publications

Use of coronary stent grafts for the treatment of high-flow carotid cavernous fistula

Use of coronary stent grafts for the treatment of high-flow carotid cavernous fistula

The Management of Intracranial Aneurysms: Current Trends and Future Directions

The use of PK Papyrus covered coronary stent for carotid reconstruction: an initial institutional experience

Contact Info

Product

Resources

About